share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股sec公告 ·  04/17 01:55
牛牛AI助理已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of the company's stock on April 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action reflects a change in Bourla's investment in the company, but without additional information, the impact on his total holdings remains unclear.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of the company's stock on April 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action reflects a change in Bourla's investment in the company, but without additional information, the impact on his total holdings remains unclear.
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布拉於2024年4月15日執行了該公司股票的交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。該行動反映了Bourla對該公司的投資的變化,但如果沒有其他信息,對其總持股的影響尚不清楚。
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布拉於2024年4月15日執行了該公司股票的交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。該行動反映了Bourla對該公司的投資的變化,但如果沒有其他信息,對其總持股的影響尚不清楚。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。